ENTRY       D02166                      Drug
NAME        Mitoxantrone hydrochloride (JAN/USP);
            Novantron (TN)
PRODUCT
  GENERIC   MITOXANTRONE (Fresenius Kabi USA)
            MITOXANTRONE (Hospira)
FORMULA     C22H28N4O6. 2HCl
EXACT_MASS  516.1542
MOL_WEIGHT  517.4028
CLASS       Antineoplastic
             DG01727  Anthraquinone antineoplastic
             DG01529  Topoisomerase inhibitor
              DG01527  Topoisomerase II inhibitor
            Transporter substrate
             DG02861  ABCC2 substrate
             DG01913  ABCG2 substrate
REMARK      Therapeutic category: 4291
            ATC code: L01DB07
            Chemical structure group: DG00701
            Product (DG00701): D02166<JP/US>
EFFICACY    Antineoplastic, Topoisomerase II inhibitor
  DISEASE   Multiple sclerosis [DS:H01490]
            Prostate cancer [DS:H00024]
            Acute leukemia [DS:H00003 H00001 H00002]
TARGET      TOP2 [HSA:7153 7155] [KO:K03164]
METABOLISM  Transporter: ABCG2 [HSA:9429], ABCC2 [HSA:1244]
INTERACTION  
STR_MAP     map07042  Antineoplastics - agents from natural products
OTHER_MAP   map04976  Bile secretion
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
                L01DB Anthracyclines and related substances
                 L01DB07 Mitoxantrone
                  D02166  Mitoxantrone hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Mitoxantrone
                D02166  Mitoxantrone hydrochloride (JAN/USP)
             Central Nervous System Agents
              Multiple Sclerosis Agents
               Mitoxantrone
                D02166  Mitoxantrone hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D02166  Mitoxantrone hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01727  Anthraquinone antineoplastic
               DG00701  Mitoxantrone
                D02166  Mitoxantrone hydrochloride
              DG01529  Topoisomerase inhibitor
               DG01527  Topoisomerase II inhibitor
                DG00701  Mitoxantrone
                 D02166  Mitoxantrone hydrochloride
             Transporter substrate
              DG02861  ABCC2 substrate
               DG00701  Mitoxantrone
                D02166  Mitoxantrone hydrochloride
              DG01913  ABCG2 substrate
               DG00701  Mitoxantrone
                D02166  Mitoxantrone hydrochloride
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Isomerases (EC5)
               DNA topoisomerase
                TOP2
                 D02166  Mitoxantrone hydrochloride (JAN/USP) &lt;JP/US&gt;
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug transporters
              D02166
            Drug groups [BR:br08330]
             Antineoplastic
              DG01727  Anthraquinone antineoplastic
               DG00701  Mitoxantrone
              DG01529  Topoisomerase inhibitor
               DG01527  Topoisomerase II inhibitor
                DG00701  Mitoxantrone
             Transporter substrate
              DG02861  ABCC2 substrate
               DG00701  Mitoxantrone
              DG01913  ABCG2 substrate
               DG00701  Mitoxantrone
DBLINKS     CAS: 70476-82-3
            PubChem: 7849227
            ChEBI: 50727
            LigandBox: D02166
            NIKKAJI: J245.513G
ATOM        34
            1   C8x C    14.8029  -16.3363
            2   C8x C    14.8029  -17.7373
            3   C8y C    16.0202  -18.4414
            4   C8y C    16.0202  -15.6392
            5   C8y C    17.2304  -16.3363
            6   C8y C    17.2245  -17.7373
            7   C5x C    18.4357  -18.4465
            8   C5x C    18.4475  -15.6443
            9   C8y C    19.6519  -16.3466
            10  C8y C    19.6393  -17.7439
            11  C8y C    20.8442  -18.4571
            12  C8x C    22.0618  -17.7657
            13  C8x C    22.0743  -16.3684
            14  C8y C    20.8693  -15.6622
            15  O1a O    16.0068  -14.2381
            16  O5x O    18.5059  -14.2381
            17  N1b N    20.8580  -14.2592
            18  O1a O    16.0068  -19.8426
            19  O5x O    18.4219  -19.8426
            20  N1b N    20.8369  -19.8566
            21  C1b C    22.0691  -13.5480
            22  C1b C    23.2800  -14.2521
            23  N1b N    24.4910  -13.5409
            24  C1b C    25.7021  -14.2450
            25  C1b C    26.9130  -13.5339
            26  O1a O    28.1241  -14.2381
            27  C1b C    22.0480  -20.5536
            28  C1b C    23.2589  -19.8495
            29  N1b N    24.4699  -20.5465
            30  C1b C    25.6810  -19.8426
            31  C1b C    26.8919  -20.5396
            32  O1a O    28.1030  -19.8355
            33  X   Cl   31.9160  -17.2232
            34  X   Cl   31.9160  -17.2232
BOND        34
            1     4  15 1
            2     6   7 1
            3     8  16 2
            4     7  10 1
            5    14  17 1
            6     9   8 1
            7     3  18 1
            8     8   5 1
            9     7  19 2
            10    5   4 2
            11   11  20 1
            12    4   1 1
            13   17  21 1
            14   21  22 1
            15    1   2 2
            16   22  23 1
            17    2   3 1
            18   23  24 1
            19    3   6 2
            20   24  25 1
            21    9  10 2
            22   25  26 1
            23   10  11 1
            24   20  27 1
            25   11  12 2
            26   27  28 1
            27   12  13 1
            28   28  29 1
            29   13  14 2
            30   29  30 1
            31   14   9 1
            32   30  31 1
            33    5   6 1
            34   31  32 1
BRACKET     1    30.5900  -18.1300   30.5900  -16.3100
            1    32.8300  -16.3100   32.8300  -18.1300
            1  2
  ORIGINAL  1   33
  REPEAT    1   34
///
